New Drug To Aid Cancer Patients

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Promising new cancer-fighting drugs are the big topic at a conference in Chicago this week.

The drugs are proving effective against prostate, lung and breast cancers, beyond the first year of treatment.

Studies suggest the drug Zytiga will become a first-treatment choice for men whose prostate cancer has spread.

For advanced lung cancer with a certain gene flaw, the drug Alecensa stopped cancer growth for 15 months longer than current medication and a relatively new drug called Lynparza showed promise.

For women with a gene that raises their risk for breast cancer.

Segment Sponsored By: Mercy Health Systems

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.